Cardiovascular and Kidney Effects of Sodium Glucose Cotransporter Inhibitors
OVERVIEW OF MECHANISM OF ACTION The sodium-glucose cotransporter (SGLT)-2 inhibitors are glucose-lowering agents initially approved for use in patients with type 2 diabetes. They exert their antihyperglycemic effects through the…
read more
